关于作者

穆罕默德·喬布蘭

監管顧問(藥劑師理學學士、生物醫學資訊學碩士)。擁有 19 年的 SFDA 和跨國公司工作經驗,並擔任專業顧問。

Navigating the SFDA medical device registration in Saudi Arabia, particularly the Medical Device Marketing Authorization (MDMA) process, is essential for manufacturers seeking entry into the rapidly expanding Saudi market.

The MDMA requirements have evolved to accommodate the advancement of international standards, such as the transition from the EU Medical Device Directives (MDD) to the Medical Device Regulations (MDR). The continuous development of medical device regulations in Saudi Arabia has increased the complexity of this process.

For example, even low-risk medical devices (supplies and consumables) became in need of an authorised representative (AR) and an MDMA approval.

We at PharmaKnowl offer expert support for the registration process. Whether you’re introducing new devices or modifying existing products, our team provides the strategic insight and technical expertise necessary to achieve a timely and successful market entry in Saudi Arabia.

This article clarifies the SFDA medical device registration requirements and defines the classification differences.

有关其他类型的商品注册,请参阅 SFDA 注册 站。

Registration Application Types

The SFDA regulates medical device products in Saudi Arabia to ensure their safety, efficacy, and quality. The manufacturers must acquire MDMA approval before marketing their products. Post-approval, they are responsible for safety reporting and other life cycle management operations, such as updates, renewals, and Unique Device Identification (UDI) submission.

以下是医疗器械注册程序的摘要:

MDNR(低风险) – 已取消

Companies used to register Non-sterile, non-measuring, Low-Risk Medical Devices through the Medical Device National Registry (MDNR), also known as “Medical Devices Listing,” which is exempt from MDMA and AR. However, in September 2022, the SFDA cancelled the MDNR procedure. Therefore, all devices must have a technical file for MDMA with an appointed AR in Saudi Arabia.

MDMA 1 (GHTF) – 已取消

在此申请途径中, SFDA 考虑了欧盟、美国、加拿大、澳大利亚和日本等 GHTF 成员国的批准。这是一条无需深入技术咨询即可轻松遵循的路线。然而,到 2021 年底, SFDA 已经取消了这条 GHTF 路线。

If you initially registered your product through MDMA 1, you can still use the same route to file renewals, minor updates, or variations. But the SFDA will still request the full technical file during the process.

MDMA 2 (反式脂肪)

From January 2022, all medical devices and in vitro diagnostics (IVDs) must receive an SFDA authorisation through the Technical File Application (TFA) registration route (MDMA2). This route resulted from the authority’s continuous updates to its regulations, influenced by the EU MDR and IVDR. It requires presenting the technical documentation in a clear, searchable, and organised manner.

因此,注册要求变得更加严格。必须满足许多条件,并且必须提供研究,例如临床评估报告 (CER)、生物相容性测试报告,以及需要在沙特阿拉伯进行上市后临床随访 (PMCF) 研究。

Although the TFA requirements are similar to those of the EU (CE mark), the SFDA does not require a CE certificate. However, if the product file doesn’t carry a CE mark, it will undergo a rigorous assessment.

注册要求

下面总结了这些要求,这些要求因商品类型和分类而异。以下是注册文件的高级部分:

  • Administrative & Product Identification
    • Table of contents
    • 设备描述
    • 预期用途/目的
    • Device Classification
    • Model, Sizes, Accessories, and Variants
    • Device Label and Packaging Information
    • Instructions for use (IFU)
    • 设计信息
    • 制造信息
    • Device History (Approvals from Reference Countries)
  • Safety, Risk & Performance Documentation
    • Essential Principles (EP List) of Safety & Performance (Required checklist)
    • 收益-风险分析
    • 风险管理文件(计划和报告)
    • Preclinical testing data
    • Biocompatibility Test Reports.
    • Electrical Safety, EMC, Software validation (as applicable)
    • Sterilisation and Shelf-Life Validation (if sterile)
  • Clinical Evaluation & Surveillance

Download: Checklist of SFDA Medical Device Required Files for MDMA application

MDMA 注册和审批流程 SFDA 沙特阿拉伯

注册流程

Time needed: 90 days

我们可以将医疗器械注册 (MDMA) 审批流程总结为以下几个步骤:

  1. 指定授权代表 (AR)

    Manufacturers must appoint an AR to represent their company in Saudi Arabia. An AR license will be issued by SFDA, after which the AR can apply for the device registration.

  2. 差距分析

    The applicant must conduct a thorough gap analysis of the registration file against all applicable requirements. Identifying the gaps is essential to determining the relevant studies and tests, such as Stability, CER, Biocompatibility, risk management, and PMCF.

  3. MDMA 提交

    申请人向 SFDA 提交技术文件。

  4. 验证

    SFDA 确保在不评估其内容的情况下进行良好的提交实践。

  5. 费用支付

    The applicant will receive an SFDA invoice to pay before the start of the assessment.

  6. 应用程序评估

    The SFDA evaluators will review the file and send back their inquiries in multiple waves.

  7. MDMA 认证

    The legal manufacturers receive an MDMA certificate that permits them to market the product in Saudi Arabia.

分类

Applicants must classify their products according to the SFDA medical device classification rules within the MDMA application. These rules correspond to the EU regulation (CE certificate) since they are the unofficial SFDA reference regulations, but do not necessarily match them.

医疗设备

SFDA medical device classification is either Class A, B, C, or D, based on the risk class. The class is necessary to determine the registration procedure and its requirements, as discussed in the table below:

SFDA 分类风险级别MDR 分类规则
A 类
A 级 – 无菌中低
A 类 – 测量功能中低
A 类 – 可重复使用的手术器械中低红外
B 类中低IIa 型
C 类中高IIb 型
D 类第三
Medical Device Classification in the Saudi Food and Drug Authority (SFDA)

分类依据如下:

  • 预期用途。
  • 风险级别(对患者、用户和其他人造成伤害的可能性和严重性)。
  • Nature of the device on or within the human body (e.g. invasive)
  • Use duration (transient, short-term, long-term)

Identical devices could be classified differently according to the targeted body part or clinical setting. Therefore, the intended use is crucial in determining the correct classification. The intended use reference is reflected in the following:

  • 使用说明 (IFU)
  • 标签
  • 宣传材料
  • 技术文件

In Vitro Diagnostics (IVDs)

For in vitro diagnostic medical devices, the SFDA employs a risk-based classification system that is broadly aligned with the International Medical Device Regulators Forum (IMDRF) principles and is similar in structure to the EU IVDR, although it is applied independently.

SFDA IVD 分类风险 级别分类规则
A 类低个人风险和低公共卫生风险一个
B 类中等个人风险和/或低公共卫生风险B
C 类高个人风险和/或中等公共卫生风险C
D 类高个人风险和高公共卫生风险D
IVD Classification in the Saudi Food and Drug Authority (SFDA)

申请人负责通过以下方式确定 IVD 的类别:

  • 应用 IVD 医疗器械的分类规则,以及
  • 考虑到:
    • 有可能的使用
    • 风险水平

Bundling Multiple Devices

Grouping multiple devices in the same application is permissible; the applicant may bundle up to 50 items in one MDMA application. However, products must meet several conditions, such as having the same legal manufacturer, the same risk class, and the same intended use.

Bundling TypeCriteriaExamples
Single ProductA device sold in multiple sizes or models with the same intended useSyringes with different volumes
FamilyDevices with the same risk class, manufacturer, design, and intended useCatheters of varying lengths
SystemDevices intended to operate together for a common purposeECG machine + electrodes + leads
SetDevices packaged together and intended for a common medical purposeSurgical kits or dental kits
Software SuiteRelated software modules that work as part of the same platformHospital management or imaging analysis software
IVD’sCan be bundled in case of the same risk class, manufacturer, design, and intended useBlood collection tubes, Culture media

时间线

The assessment timelines vary according to several factors, including risk class, product complexity, the number of bundled products, and the completeness of the file. Unidentified gaps before the submission may delay the approval. The entire timeline for the registration project includes:

  • Gap Analysis Time
    This part depends on the number and type of gaps, the speed of manufacturer feedback, and the regulatory staff’s experience.
  • SFDA 评估时间
    有关官方审核时间表,请参阅我们的文章 SFDA 时间表

费用

MDMA 申请费用根据医疗器械风险等级和申请中的商品数量而有所不同。有关更多信息,请参阅我们更新的 SFDA 费用 博文。

更新

MDMA’s default validity is three years. When the license is near expiration, manufacturers can submit an MDMA renewal application up to three months (90 days) before the expiration date. If registered in the obsolete MDMA1 (GHTF) application, the renewal process would be long and require extensive additional technical files and studies, just like a new registration. In contrast, MDMA2 renewal will be faster.

更新

要更改已注册的医疗器械,制造商必须提交 MDMA 更新 申请。

MDMA 证书

SFDA 将颁发阿拉伯语和英语的 MDMA 证书,其中包含以下内容:

  • The manufacturer’s information (License Holder)
  • Medical Device Name and Medical Device Group Information.
  • 有效期
  • 证书编号
MDMA 证书的标头

产品分类

以下是沙特阿拉伯的医疗器械类型和类别示例:

  • 诊断设备:
    • 成像设备:X 光机、CT 扫描仪。
    • 监测设备:心电图机和血压监测仪。
    • 体外诊断设备:妊娠试验、血糖仪。
  • 治疗设备:
    • 呼吸设备:呼吸机、雾化器。
    • 输液设备:胰岛素泵和静脉注射治疗设备。
    • 康复设备:轮椅、假肢。
  • 植入式设备:
    • 心血管设备:起搏器、支架。
    • 骨科植入物:髋关节置换术、脊髓杆、关节置换术。
  • 手术器械:
    • 切割工具: 手术刀、手术剪刀、镊子。
    • 吻合器和缝合线:手术吻合器、可吸收缝合线。
  • 牙科设备:
    • 修复材料: 牙冠、填充物。
    • 正畸矫治器:牙套、保持器。
    • 其他:牙钻
  • 眼科设备:
    • 矫正镜片: 隐形眼镜、眼镜。
    • 手术设备:LASIK 机器、人工晶状体。
  • 医疗软件 (SaMD):
    • 诊断软件:用于图像分析的 AI。
    • 治疗计划软件:放射治疗计划工具。
  • 实验室设备:
    • Analysers: Blood gas analysers and haematology analysers.
    • Sterilisation equipment: Autoclaves, UV sterilisers.
  • 医用气体
  • 家庭医疗保健设备:
    • 监测设备:血糖监测仪和数字温度计。
    • 助行器:助行器、电动滑板车。
  • 治疗设备(例如透析机)

医疗器械进口许可证 (MDIL)

Importing medical devices requires a valid MDMA. However, the SFDA may exempt some medical devices from registration and only require them to issue a medical device importing license (MDIL). For example:

  • Demonstration or training purposes, medical devices.
  • Chemicals (finished products), whether classified as medical devices or used in conjunction with medical devices (e.g., gases used to calibrate medical devices, as well as chemicals used to ensure the sterilisation operation of medical devices, the manufacturing of prostheses, and the preservation of tissues or cells). Excluding the following products:
    • 放射性物质
    • 医用体外诊断
    • 非医疗 IVD
    • 化学前体。
  • 用于医疗保健提供者或教育设施的蒸馏设备。
  • 研究和教育用途产品。
  • 用于本地制造的半成品医疗器械/用品(以及原材料和非原材料化学品)(制造包括翻新、组装、包装和贴标)。

公司注册

The SFDA also regulates medical device companies, enforcing different requirements for local and international companies to receive an SFDA license to manufacture, import, or distribute medical devices. Below are the requirements for both types:

当地沙特公司

The SFDA licenses local medical device companies, including importers, distributors, warehouses, authorised representatives, and manufacturers. The local company license name is the Medical Device Establishment License (MDEL). All previous types of companies must implement a quality management system (QMS) and have an ISO 13485 certificate.

International legal manufacturers must appoint an authorised representative (AR) in Saudi Arabia; this is the first step in enabling communication with the SFDA. The AR’s primary responsibility is product compliance in pre- and post-marketing activities. The AR will maintain registration status, facilitate shipments, monitor safety, report cases, and represent the company in regulatory or legal matters.

注册服务

Whether your company is new to or already active in the Saudi market, PharmaKnowl will help you comply with the SFDA and facilitate your business by providing compliance, insights, and supply management to your distributors without shipment commission.

PharmaKnowl is an SFDA-licensed service provider in Saudi Arabia representing well-known international companies. Contact us to schedule an exploratory meeting or request more information.

Frequently Asked Questions

What is Medical Device Marketing Authorisation (MDMA) in Saudi Arabia? 

MDMA is the official approval issued by the Saudi Food and Drug Authority (SFDA) that allows a medical device or IVD to be marketed in the Kingdom. It confirms that the product meets all local regulatory, safety, and performance requirements based on a review of the technical file. 

How long is the SFDA MDMA certificate valid?

The MDMA certificate is valid for three years. Renewal can be initiated up to 90 days before expiration.

Is an Authorised Representative (AR) mandatory for SFDA MDMA approval?

Yes. For international manufacturers, appointing an SFDA-licensed Authorised Representative (AR) is mandatory to submit the MDMA application and manage post-market obligations in Saudi Arabia. 

What are the timelines for MDMA registration in Saudi Arabia? 

The typical MDMA timeline is 35 business days if all requirements are fulfilled, but the timeline can vary due to technical file gaps, product complexity, or missing documentation.

Can multiple medical devices be registered under one MDMA application?

Yes. A maximum number of 50 medical devices can be grouped/bundled into a single MDMA application as long as they meet bundling criteria. 

What happens if I miss the MDMA renewal deadline?

The company is not allowed to market its product when the certificate expires. The company must renew its license as soon as possible to ensure its AR license remains valid.

Does SFDA accept the CE mark or the US FDA approval?

While prior approval (e.g., CE mark, FDA 510(k)) can support your application, the SFDA conducts an independent evaluation. MDMA approval is not granted automatically based on foreign registrations. SFDA does not require CE or FDA approval as long as the full technical file is available according to SFDA requirements.  

What’s the difference between MDMA and MDEL?

MDMA applies to the product registration certificate for a medical device or IVD in KSA, while MDEL is the importer or distributor license.

What’s the difference between MDMA-1 and MDMA-2?

MDMA-1: Registration route based on approvals from Global Harmonisation Task Force (GHTF) countries: EU, US, Canada, Australia, Japan. It was easier and faster without the need for complete technical files. However, this route was cancelled by SFDA and replaced with MDMA 2.
MDMA 2, which is the current registration route (since 2022). It requires complete Saudi-specific technical files (similar to EU MDR standards) and undergoes a more stringent SFDA evaluation. It does not require any prior GHTF approvals.

Categories: 洞察力, 特色Tags:

关于作者

穆罕默德·喬布蘭

監管顧問(藥劑師理學學士、生物醫學資訊學碩士)。擁有 19 年的 SFDA 和跨國公司工作經驗,並擔任專業顧問。

资源

服务业

事件

有问题吗?让我们连接..

联系我们安排电话、索取详细信息或获取量身定制的提案。